Hypothesis

Age‑related protein aggregates are not merely inert deposits; they actively bind redox‑active transition metals (Fe²⁺/Fe³⁺, Cu⁺/Cu²⁺) and thereby suppress Fenton‑chemistry–driven oxidative damage. When proteostasis capacity declines, the cell directs misfolded proteins into organized aggregates (JUNQ/IPOD, stress granules, aggresomes) that present high‑density surfaces rich in histidine, cysteine and carboxylate side chains, creating a chemoselective sink for metal ions. By sequestering these metals, aggregates lower the labile iron and copper pools, decreasing hydroxyl‑radical generation and protecting vital macromolecules. Dissolution of aggregates—whether by pharmacological disaggregases or by overriding sequestration signals—would release the stored metals, precipitating a burst of oxidative stress that could explain why attempts to clear aggregates sometimes worsen phenotypes.

Mechanistic Basis

• Histidine‑rich motifs in many aggregation‑prone proteins (e.g., tau, α‑synuclein) have high affinity for Cu²⁺ and Fe³⁺ (3).
• Cysteine residues exposed in β‑sheet‑rich cores can coordinate Fe²⁺ via thiolate bonds, a chemistry observed in bacterial inclusion bodies (4).
• The JUNQ/IPOD compartmentalization system already shows chaperone enrichment, suggesting a controlled environment amenable to metal binding (1).
• Long‑lived C. elegans accumulate chaperone‑rich aggregates that correlate with reduced oxidative stress markers (2).
• In E. coli, polar aggregates buffer aging effects, possibly by limiting metal‑catalyzed damage (4).

Thus, aggregation may represent a redox‑homeostasis layer that operates when canonical antioxidant systems (e.g., glutathione, superoxide dismutase) are overwhelmed.

Testable Predictions

1. Metal content – Isolated IPOD/JUNQ fractions from aged mammalian brain will contain significantly higher levels of labile iron and copper than soluble fractions, measurable by ICP‑MS after chelator‑extraction (5).
2. Oxidative read‑out – Cells expressing aggregation‑prone proteins will show lower ROS (e.g., DHE fluorescence) when aggregates are intact; acute disaggregation (via overexpression of Hsp104 or small‑molecule disaggregases) will cause a transient ROS spike that correlates with released metal pools.
3. Genetic manipulation – Knock‑down of metal‑binding residues (His→Ala, Cys→Ser) in an aggregation‑prone protein will reduce aggregate‑associated metal accumulation and increase sensitivity to oxidative stress, despite unchanged aggregate load.
4. Pharmacological challenge – Treating aged mice with a membrane‑permeable iron chelator (deferiprone) should phenocopy the protective effect of aggregates, reducing oxidative damage even when aggregate formation is inhibited; conversely, copper supplementation should exacerbate toxicity only in animals with impaired aggregation capacity.
5. Lifespan correlation – In C. elegans, strains that over‑express metal‑sequestering aggregate‑prone proteins will exhibit extended lifespan only under conditions of elevated iron/copper exposure; the benefit will disappear when metal chelators are added, indicating that the protective effect is metal‑dependent.

Potential Experiments

• Fractionation & metal assay: Sucrose gradient separation of brain lysates from young vs. old mice, followed by immunoblot for aggregate markers (p‑tau, α‑synuclein) and parallel ICP‑MS quantification of Fe/Cu.
• ROS dynamics: Live‑cell imaging of ROS using HyPer sensor in HEK293 cells expressing mutant SOD1; monitor ROS before and after induction of disaggregation by arsenite‑shock or Hsp104 overexpression.
• Mutagenesis: Generate CRISPR‑edited tau lines where all surface histidines are mutated to alanine; assess aggregate formation (filter‑trap assay), metal content (X‑ray fluorescence microscopy), and susceptibility to H₂O₂‑induced death.
• Metal supplementation: Feed C. elegans with FeCl₂ or CuSO₄ at sub‑lethal concentrations; compare survival of wild‑type vs. lines overexpressing an aggregation‑prone, metal‑binding peptide (e.g., poly‑His tag fused to GFP).
• Chelator rescue: Treat aged Drosophila expressing toxic Aβ42 with deferiprone; measure lifespan, oxidative protein carbonyls, and aggregate load via Thioflavin‑T staining.

If aggregates serve as redox sinks, disrupting their metal‑binding capacity should uncouple aggregate load from toxicity, revealing that the harmful species are not the fibrils themselves but the labile metals they sequester. This hypothesis directly challenges the prevailing view that aggregate dissolution is uniformly beneficial and offers a clear, falsifiable framework for re‑evaluating anti‑aggregation therapies in neurodegenerative aging.